Trial Number
346-23
Condition
Pediatric Cancer
Participant Age Range
up to 21 Years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma”
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma.